Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Novoheart International Limited currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units, showing that the company's prosecution efforts are not centralized under a single individual. This distribution across 2 distinct art units may require the company to adapt to different examination styles within the broader field of Medical Devices & Mechanical Engineering.
The busiest examiner for this portfolio is MCCALISTER, WILLIAM M, who is responsible for 1 pending office action. Given that there are 2 pending office actions in total, the workload is split evenly, with the other action assigned to the second of the 2 distinct examiners. This arrangement means that no single examiner dominates the company's current prosecution landscape, as MCCALISTER, WILLIAM M only handles a portion of the pending matters.
The involvement of 2 distinct examiners and 2 distinct art units for only 2 pending office actions indicates variety in the company's current patent office interactions. Practitioners should be prepared for the specific requirements of the 2 distinct art units involved. With 1 pending office action under MCCALISTER, WILLIAM M, the company must manage two separate prosecution tracks to address the 2 pending office actions currently on record.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCALISTER, WILLIAM M | 1 | 69.0% | +19.6% |
| REGLAS, GILLIAN CHELSEA | 1 | 30.2% | +41.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17143795 | MICROFABRICATED DEVICES AND HIGH THROUGHPUT ASSAYS FOR MODULATORS OF CELL BEHAVIOR | REGLAS, GILLIAN CHELSEA | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17143795 | MICROFABRICATED DEVICES AND HIGH THROUGHPUT ASSAYS FOR MODULATORS OF CELL BEHAVIOR | REGLAS, GILLIAN CHELSEA | 14d |
| 18260754 | LOW PRESSURE VALVE ASSEMBLIES | MCCALISTER, WILLIAM M | — |
| Art Unit | Apps |
|---|---|
| 3753 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260754 | LOW PRESSURE VALVE ASSEMBLIES | MCCALISTER, WILLIAM M | 3753 | §103 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 17143795 | MICROFABRICATED DEVICES AND HIGH THROUGHPUT ASSAYS FOR MODULATORS OF CELL BEHAVIOR | REGLAS, GILLIAN CHELSEA | 1632 | §103§112 | Non-Final OA | 14d | Pending | Jan 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial